Researchers at U of T Engineering have developed a new way of growing realistic human tissues outside the body. Their “person-on-a-chip” technology, called AngioChip, is a powerful platform for discovering and testing new drugs, and could eventually be used to repair or replace damaged organs.
Professor Milica Radisic (IBBME, ChemE), graduate student Boyang Zhang and their collaborators are among those research groups around the world racing to find ways to grow human tissues in the lab, under conditions that mimic a real person’s body. They have developed unique methods for manufacturing small, intricate scaffolds for individual cells to grow on. These artificial environments produce cells and tissues that resemble the real thing more closely than those grown lying flat in a petri dish.
he team’s recent creations have included BiowireTM — an innovative method of growing heart cells around a silk suture — as well as a scaffold for heart cells that snaps together like sheets of Velcro™. But AngioChip takes tissue engineering to a whole new level. “It’s a fully three-dimensional structure complete with internal blood vessels,” says Radisic. “It behaves just like vasculature, and around it there is a lattice for other cells to attach and grow.” The work — which is published todayin the journal Nature Materials — was produced collaboratively with researchers from across U of T, including Professor Michael Sefton (ChemE, IBBME), Professor Aaron Wheeler (Chemistry, IBBME) and their research teams, as well as researchers from Toronto General Hospital and University Health Network.
Zhang built the scaffold out of POMaC, a polymer that is both biodegradable and biocompatible. The scaffold is built out of a series of thin layers, stamped with a pattern of channels that are each about 50 to 100 micrometres wide. The layers, which resemble the computer microchips, are then stacked into a 3D structure of synthetic blood vessels. As each layer is added, UV light is used to cross-link the polymer and bond it to the layer below.
When the structure is finished, it is bathed in a liquid containing living cells. The cells quickly attach to the inside and outside of the channels and begin growing just as they would in the human body.
“Previously, people could only do this using devices that squish the cells between sheets of silicone and glass,” says Radisic. “You needed several pumps and vacuum lines to run just one chip. Our system runs in a normal cell culture dish, and there are no pumps; we use pressure heads to perfuse media through the vasculature. The wells are open, so you can easily access the tissue.”
Using the platform, the team has built model versions of both heart and liver tissues that function like the real thing. “Our liver actually produced urea and metabolized drugs,” says Radisic. They can connect the blood vessels of the two artificial organs, thereby modelling not just the organs themselves, but the interactions between them. They’ve even injected white blood cells into the vessels and watched as they squeezed through gaps in the vessel wall to reach the tissue on the other side, just as they do in the human body.
AngioChip has great potential in the field of pharmaceutical testing. Current drug-testing methods, such as animal testing and controlled clinical trials, are costly and fraught with ethical concerns. Testing on lab-grown human tissues would provide a realistic model at a fraction of the cost, but this area of research is still in its infancy. “In the last few years, it has become possible to order cultures of human cells for testing, but they’re grown on a plate, a two-dimensional environment,” says Radisic. “They don’t capture all the functional hallmarks of a real heart muscle, for example.”
A more realistic platform like AngioChip could enable drug companies to detect dangerous side effects and interactions between organ compartments long before their products reach the market, saving countless lives. It could also be used to understand and validate the effectiveness of current drugs and even to screen libraries of chemical compounds to discover new drugs. Through TARA Biosystems Inc., a spin-off company co-founded by Radisic, the team is already working on commercializing the technology.
In future, Radisic envisions her lab-grown tissues being implanted into the body to repair organs damaged by disease. Because the cells used to seed the platform can come from anyone, the new tissues could be genetically identical to the intended host, reducing the risk of organ rejection. Even in its current form, the team has shown that the AngioChip can be implanted into a living animal, its artificial blood vessels connected to a real circulatory system. The polymer scaffolding itself simply biodegrades after several months.
The Latest on: Tissue engineering
via Google News
The Latest on: Tissue engineering
- Dr. Sina Rabbany will discuss tissue engineering, regenerative medicine at Emanuelon November 22, 2019 at 11:44 am
Dr. Sina Rabbany will offer Issues in Medicine talk at Emanuel, Tues., Dec. 10 at 7:30 p.m. Sina Y. Rabbany will offer an Issues in Medicine lecture, “Tissue Engineering and Regenerative Medicine,” at ...
- Biomaterials and Tissue Engineeringon November 14, 2019 at 6:48 pm
The focus of the Biomaterials and Tissue Engineering concentration is creating polymeric materials and engineered tissue constructs to be used in novel medical therapy. This program will provide ...
- Japan Tissue Engineering Co Ltdon November 12, 2019 at 10:00 pm
Data delayed at least 20 minutes, as of Nov 13 2019 06:00 GMT. Take a deeper look into a company's insider transactions by viewing director purchases and sales by individual directors. 5-year ...
- Tissue Engineering Market Size 2020 Regional Trend & Growth Projections to 2028on November 12, 2019 at 1:39 am
(MENAFN - America News Hour) TotalHealthcare Spending around the Globe was USD 7.5 Trillion in 2016 – W.H.O. CRIFAX added a report on ' Global Tissue Engineering Market, 2020-2028' to its database of ...
- Beijing University of Chemical Technology: 3D Printed HA/PCL Tissue Engineering Scaffoldson November 8, 2019 at 11:11 pm
3D printed bone scaffolds used for tissue engineering purposes need to have a good amount of mechanical strength, since the scaffold needs to be able to provide support for the tissue. As bone ...
- Tissue Engineering Market 2019 With Top Countries Data : Industry Trends, Share, Size, Top Key Players Analysis and Forecast Researchon November 8, 2019 at 1:54 am
Tissue Engineering Market2019 Research report contains a qualified and in-depth examination of Tissue Engineering Market. At first, the report provides the current Tissue Engineering business ...
- Tissue Engineering Market 2019 to 2024 With Top Countries Data : Opportunities, Industry Trends and Policies by Regions and Companieson November 8, 2019 at 1:29 am
Nov 08, 2019 (The Expresswire) -- The worldwide market for Tissue Engineering is expected to grow at a CAGR of roughly 18.8% over the next five years, will reach 39300 million US$ in 2024, from 14000 ...
- 3D printing system used to accelerate tissue engineering research at The University of Sheffieldon November 4, 2019 at 1:07 am
A new technique is needed, and this is where tissue engineering fits in, enabling new blood vessels to be grown in the lab and then used for implantation. Dr. Sam Pashneh-Tala from the University of ...
- Tissue engineering in N.H. topic of Science Cafeon November 1, 2019 at 5:00 pm
Now, the topic of tissue engineering has returned to the forefront as New Hampshire’s own visionary, Dean Kamen, has helped spark a new initiative around this very area in the heart of New Hampshire’s ...
- Muscle tissue engineering in fibrous gelatin: implications for meat analogson October 21, 2019 at 2:13 am
To verify that gelatin fibers produced by iRJS support muscle tissue engineering, we spun microfibrous gelatin scaffolds and seeded them with bovine aortic smooth muscle cells (BAOSMCs) and rabbit ...
via Bing News